These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 16574456

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA, Wagner FF, Fernandes BJ, Li W, Flegel WA.
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?
    Brinc D, Le-Tien H, Crow AR, Freedman J, Lazarus AH.
    Br J Haematol; 2007 Oct; 139(2):275-9. PubMed ID: 17897303
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Specificity and isotype of Rh specific antibodies produced by human B-cell lines established from alloimmunized Rh negative women.
    Pasha RP, Bahrami ZS, Niroomanesh S, Ramzi F, Razavi AR, Shokri F.
    Transfus Apher Sci; 2005 Oct; 33(2):119-27. PubMed ID: 16103012
    [Abstract] [Full Text] [Related]

  • 9. Rh proteins: key structural and functional components of the red cell membrane.
    Van Kim CL, Colin Y, Cartron JP.
    Blood Rev; 2006 Mar; 20(2):93-110. PubMed ID: 15961204
    [Abstract] [Full Text] [Related]

  • 10. Maternal red blood cell alloimmunisation in south western Uganda.
    Natukunda B, Mugyenyi G, Brand A, Schonewille H.
    Transfus Med; 2011 Aug; 21(4):262-6. PubMed ID: 21371143
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM.
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Do we need to be more concerned about weak D antigens?
    Garratty G.
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract] [Full Text] [Related]

  • 16. The role of the fetal immune system in the pathogenesis of RhD-hemolytic disease of newborns.
    Gurevich P, Erina S, Gershon S, Zusman I.
    Hum Antibodies; 1997 Oct; 8(2):76-89. PubMed ID: 9289392
    [Abstract] [Full Text] [Related]

  • 17. [Alloimmunization to a high frequency Rh antigen].
    Cotorruelo C, Biondi C, Borras SG, Racca L, Brunetti D, Di Monaco R, Racca A.
    Medicina (B Aires); 2006 Oct; 66(1):46-8. PubMed ID: 16555729
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R, Shokri F.
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [Abstract] [Full Text] [Related]

  • 20. [Anti-c antibodies as a cause of severe form of hemolytic disease of the newborn].
    Sławek Z, Stolarz E, Banaszkiewicz A, Walczak Z, Surowiec E.
    Acta Haematol Pol; 1988 Dec; 19(1-2):71-4. PubMed ID: 3149113
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.